BioNTech SE (BNTX) Finished Goods (2018 - 2021)

BioNTech SE has disclosed Finished Goods across 4 years of filings, most recently posting $194.1 million for Q4 2021.

• Finished Goods for Q4 2021 came in at $194.1 million, up 40605.68% year-over-year; the trailing twelve-month figure through Dec 2021 was $194.1 million (up 40605.68% YoY), and the FY2021 annual result was $194.1 million, up 40605.68% from the prior year.
• Finished Goods came in at $194.1 million for Q4 2021 at BioNTech SE, up from $476915.9 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $194.1 million in Q4 2021 to a low of $476915.9 in Q4 2020.
• The 4-year median for Finished Goods is $1.1 million (2018), against an average of $49.2 million.
• Across the five-year window, Finished Goods sank 50.25% in 2019 and jumped 40605.68% in 2021, its largest moves.
• BioNTech SE's Finished Goods stood at $1.4 million in 2018, then tumbled by 50.25% to $700659.9 in 2019, then plunged by 31.93% to $476915.9 in 2020, then surged by 40605.68% to $194.1 million in 2021.
• The last three Finished Goods figures came in at $194.1 million (Q4 2021), $476915.9 (Q4 2020), and $700659.9 (Q4 2019), per Business Quant data.